App-Quantinova.ai

COMPLEMENT IN THE RHEUMATIC DISEASE: COMPLEMENTOPATHIES

M. C. Pickering - European League Against Rheumatism (EULAR) , 2013

Therapeutic Area

Disease

Drug/Treatment

Nephrology

Venous thrombosis

Eculizumab

VARIATION OF ANTIPHOSPHOLIPID ANTIBODY (APL) TITERS IN PATIENTS WITH PERSISTENT ANTIPHOSPHOLIPID ANTIBODIES

C. Vegas - European League Against Rheumatism (EULAR) , 2013

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Venous thrombosis

N/A

A CT EVALUATION OF PULMONARY AND CARDIAC LESIONS IN BEHCE-S SYNDROME PATIENTS WITHOUT PULMONARY SYMPTOMS

E. Seyahi - European League Against Rheumatism (EULAR) , 2013

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Venous thrombosis

Methadone hydrochloride

MEGACAPILLARIES AS DETECTED BY NAILFOLD VIDEOCAPILLAROSCOPY IN A COHORT OF PATIENTS WITH ACROCYANOSIS

R. Irace - European League Against Rheumatism (EULAR) , 2013

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Venous thrombosis

N/A

THE CHALLENGE OF SUPPORTING A PERSON WITH RMD TO BECOME A PARENT- A CLINICAL PERSPECTIVE

A. Tincani - European League Against Rheumatism (EULAR) , 2013

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Venous thrombosis

Cyclophosphamide

INVESTIGATION OF TNFRSF1A (TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY, MEMBER 1A) GENE POLYMORPHISMS IN BEHCE-S DISEASE

E. Erken - European League Against Rheumatism (EULAR) , 2013

Therapeutic Area

Disease

Drug/Treatment

Obstetrics/Gynecology

Venous thrombosis

Nicardipine Hydrochloride

THE ASSOCIATION BETWEEN P-SELECTIN POLYMORPHISMS AND THROMBOSIS IN ANTIPHOSPHOLIPID SYNDROME: A PILOT STUDY

N. A. Kanitez - European League Against Rheumatism (EULAR) , 2013

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Venous thrombosis

N/A

EFFECTS OF RALOXIFENE FOR PREVENTION OF BONE LOSS IN RHEUMATOID ARTHRITIS WOMEN RECEIVING LONG-TERM GLUCOCORTICOIDS

S. Stoica - European League Against Rheumatism (EULAR) , 2013

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

Glucocorticoid

THE RELATION BETWEEN DISEASE ACTIVITY AND FINDINGS AND MEAN PLATELET VOLUME IN BEHCE-S DISEASE

M. Uzerk Kibar - European League Against Rheumatism (EULAR) , 2013

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

ARTERIAL ANEURYSMS IN BEHCE-S DISEASE. A REPORT OF 25 CASES

T. Ben Salem - European League Against Rheumatism (EULAR) , 2013

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Methadone hydrochloride

PREDICTORS FOR OUTCOME OF JUVENILE SLE

T. Avcin - European League Against Rheumatism (EULAR) , 2013

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Venous thrombosis

Cyclophosphamide

MEAN PLATELET VOLUME AS A BIOMARKER REPRESENTING SEROPOSITIVITY AND TREATMENT RESPONSES IN RHEUMATOID ARTHRITIS

Y.A. Lee - European League Against Rheumatism (EULAR) , 2013

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Venous thrombosis

N/A

PREVENTION OF VENOUS THROMBOEMBOLIC COMPLICATIONS IN TOTAL HIP AND TOTAL KNEE ARTHROPLASTY FOR PATIENTS WITH RHEUMATIC DISEASES

A. Rybnikov - European League Against Rheumatism (EULAR) , 2013

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Venous thrombosis

Pradax

RESULTS OF TOTAL HIP PROSTHESIS IN PATIENTS WITH RHEUMATOID ARTHRITIS ACCORDING TO THE RECEIVED THERAPY

S. Lapshina - European League Against Rheumatism (EULAR) , 2013

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Venous thrombosis

Sulfasalazine

LONG-TERM TARGETED SAFETY EVENT RATES IN RA PATIENTS FOLLOWING INITIATION OF RITUXIMAB: INTERIM ANALYSIS FROM SUNSTONE REGISTRY

D. Furst - European League Against Rheumatism (EULAR) , 2013

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Venous thrombosis

Rituximab

POSTOPERATIVE COMPLICATIONS IN RHEUMATOID ARTHRITIS PATIENTS RECEIVING RITUXIMAB AND CONVENTIONAL DISEASE-MODIFYING ANTIRHEUMATIC DRUGS (DMARDS)

E. Pogozheva - European League Against Rheumatism (EULAR) , 2013

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Venous thrombosis

Methotrexate

RECURRENCE OF THROMBOTIC EVENTS IN YOUNG PATIENTS WITH PRIMARY ANTIPHOSPHOLIPID SYNDROME RELATED WITH TRIPLE POSITIVITY FOR ANTIPHOSPHOLIPD ANTIBODIES

C. Nalli - European League Against Rheumatism (EULAR) , 2013

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Venous thrombosis

N/A

HYPOVITAMINOSIS D AND THE METABOLIC SYNDROME IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS (SLE)

C. C. Mok - European League Against Rheumatism (EULAR) , 2013

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Venous thrombosis

Glucocorticoid

THE ANALYSIS OF RISK AND PROTECTIVE FACTORS FOR THROMBOSIS IN SYSTEMIC LUPUS ERYTHEMATOSUS WITH OR WITHOUT ANTIPHOSPHOLIPID ANTIBODIES

T. Watanabe - European League Against Rheumatism (EULAR) , 2013

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Venous thrombosis

N/A

COMPARISON OF MULTI-LINE DOT ASSAY AND ENZYME-LINKED IMMUNOSORBENT ASSAY FOR DETECTION OF AUTOANTIBODY PROFILE IN ANTIPHOSPHOLIPID SYNDROME

E. Alexandrova - European League Against Rheumatism (EULAR) , 2013

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Venous thrombosis

Phosphatidylinositol

Filters

7277 Abstracts